BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 27911310)

  • 1. Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AβPPswe/PSEN1dE9 Alzheimer's Disease Model Mice Fed a High-Fat Diet.
    Matsuda T; Hisatsune T
    J Alzheimers Dis; 2017; 56(1):1-23. PubMed ID: 27911310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice.
    Gong Z; Huang J; Xu B; Ou Z; Zhang L; Lin X; Ye X; Kong X; Long D; Sun X; He X; Xu L; Li Q; Xuan A
    J Neuroinflammation; 2019 Mar; 16(1):62. PubMed ID: 30871577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydrohyperforin increases adult hippocampal neurogenesis in wild-type and APPswe/PS1ΔE9 mice.
    Abbott AC; Calderon Toledo C; Aranguiz FC; Inestrosa NC; Varela-Nallar L
    J Alzheimers Dis; 2013; 34(4):873-85. PubMed ID: 23302657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
    Martins IV; Rivers-Auty J; Allan SM; Lawrence CB
    J Alzheimers Dis; 2017; 55(3):915-932. PubMed ID: 27802235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel phosphodiesterase-5 Inhibitor: Yonkenafil modulates neurogenesis, gliosis to improve cognitive function and ameliorates amyloid burden in an APP/PS1 transgenic mice model.
    Zhu L; Yang JY; Xue X; Dong YX; Liu Y; Miao FR; Wang YF; Xue H; Wu CF
    Mech Ageing Dev; 2015 Sep; 150():34-45. PubMed ID: 26200391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
    Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
    J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
    Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
    Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting neurogenesis ameliorates danger assessment in a mouse model of Alzheimer's disease.
    Shruster A; Offen D
    Behav Brain Res; 2014 Mar; 261():193-201. PubMed ID: 24388979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
    Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
    Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice.
    McClean PL; Jalewa J; Hölscher C
    Behav Brain Res; 2015 Oct; 293():96-106. PubMed ID: 26205827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
    Cantarella G; Di Benedetto G; Puzzo D; Privitera L; Loreto C; Saccone S; Giunta S; Palmeri A; Bernardini R
    Brain; 2015 Jan; 138(Pt 1):203-16. PubMed ID: 25472798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
    Liu H; Xue X; Shi H; Qi L; Gong D
    Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
    Muthukumaran K; Kanwar A; Vegh C; Marginean A; Elliott A; Guilbeault N; Badour A; Sikorska M; Cohen J; Pandey S
    J Alzheimers Dis; 2018; 61(1):221-236. PubMed ID: 29154270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Brain Magnetic Stimulation Promotes Neurogenesis and Restores Cholinergic Activity in a Transgenic Mouse Model of Alzheimer's Disease.
    Zhen J; Qian Y; Fu J; Su R; An H; Wang W; Zheng Y; Wang X
    Front Neural Circuits; 2017; 11():48. PubMed ID: 28713248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
    Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
    J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron and neuroblast numbers and cytogenesis in the dentate gyrus of aged APP
    Olesen LØ; Sivasaravanaparan M; Severino M; Babcock AA; Bouzinova EV; West MJ; Wiborg O; Finsen B
    Neurobiol Dis; 2017 Aug; 104():50-60. PubMed ID: 28461249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
    Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
    Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.